“FIB-4 ≥1.3 Is Correlated With Increased DKD Risk in T2D, But SGLT2i Therapy That Lowers FIB-4 Attenuates This ”. 2025. Diabzen 3 (4): 120-27. https://thediabzen.com/index.php/d/article/view/34.